Efficacy of individual occupational therapy for patients with schizophrenia: a multicenter randomized controlled trial
Not Applicable
- Conditions
- schizophrenia
- Registration Number
- JPRN-UMIN000019569
- Lead Sponsor
- Shinshu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
(1) patients with mental retardation (2) patients with any current or past histories of neurological disorders (3) patients with alcohol or drug disorders (abuse or dependence) (4) patients with need of individual intervention for physical dysfunction
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method (1) Brief Assessment of Cognition in Schizophrenia-Japanese version (BACS-J)
- Secondary Outcome Measures
Name Time Method (1) Schizophrenia cognition rating scale Japanese version (SCoRS-J) (2) Social functioning scale Japanese version (SFS-J) (3) Global assessment of functioning (GAF) scale (4) Positive and negative syndrome scale (PANSS) (5) Japanese version of client satisfaction questionnaire (CSQ-8J) (6) Rehospitalization rate
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What neural mechanisms underlie individual occupational therapy's efficacy in schizophrenia patients with neurocognitive deficits in the JPRN-UMIN000019569 trial?
How does individual occupational therapy in the JPRN-UMIN000019569 trial compare to standard antipsychotic treatments in improving functional outcomes for schizophrenia?
Which biomarkers predict response to individual occupational therapy in schizophrenia patients with dopamine receptor dysregulation in the JPRN-UMIN000019569 study?
What are the potential adverse events associated with individual occupational therapy in the JPRN-UMIN000019569 trial for schizophrenia, and how are they managed?
Are there combination therapies involving individual occupational therapy and pharmacological agents that enhance schizophrenia treatment outcomes in the JPRN-UMIN000019569 study?